Lung Cancer News

The percentage of patients with advanced cancers who died within a month of beginning immunotherapy rose significantly in the last decade, study results published in JAMA Oncology showed.

The FDA placed a clinical hold on a trial designed to evaluate a novel cell therapy for non-small cell lung cancer after one study participant died.

MADRID — Remarkable. Highly meaningful. Monumental.

Taofeek K. Owonikoko, MD, PhD, has been named executive director of University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

Only about one-fourth of patients newly diagnosed with advanced cancers had documented conversations with their physicians about the costs of care, according to a study conducted by researchers at American Cancer Society and NCI.

Never-smoker lung cancer survivors face a similar risk for second primary lung cancers as those who have ever smoked, according to study results published in JAMA Network Open.

Survival rates for patients with non-small cell lung cancer treated with first-line immunotherapy did not differ based on race or other socioeconomic determinants, according to a study in National Comprehensive Cancer Network.

For individuals with an incidentally detected lung nodule who are ineligible for lung cancer screening based on age, a lung nodule program may catch lung cancer early, according to results published in Journal of Thoracic Oncology.

Compared with army and air force veterans in the U.K. and Australia, naval veterans more frequently had lung cancers linked to asbestos exposure, according to results published in Scientific Reports.

Among four preventable risk factors for cancer mortality, smoking tobacco resulted in the most deaths and years of life lost in seven countries, according to data published in eClinicalMedicine.